
Photo: Medlife
BDR Pharma's Prostate Cancer Drug to be Available in 80mg in India
BDR Pharma announced that its prostate cancer drug, Enzalutamide, will be available in 80mg in India to reduce the pill burden on patients. The tablets are used to treat men with metastatic Castration-Resistant Prostate Cancer (mCRPC) and are priced at Rs 24,480 per pack, consisting of four strips. Earlier, in 2017, BDR Pharma had received authorization from the Drug Controller General of India (DCGI) for its 40mg version of Enzalutamide.